Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with Profit of 26.17%

November 30, 2022
ELI LILLY AND COMPANY, a prominent pharmaceutical company, recently saw its stock hit the forecasted price target with an impressive profit of 26.17%. The forecast signal was issued on May 6, 2022, with the stock price at 287.64 $. The predicted direction was long, and on November 30, 2022, the stock reached the target price of 362.9 $, delivering significant gains to investors.

This successful forecast is a testament to the accuracy and reliability of QuantWave's analytics in predicting stock movements. The achievement of the price target demonstrates the platform's ability to identify profitable opportunities for investors in the market. QuantWave provides users with access to predictions for a wide range of stocks, offering the potential for substantial profits.

Moving forward, investors can leverage QuantSchool, a professional investment framework that delves into the key principles for generating consistent income using the QuantWave forecasting system. By exploring the educational resources provided by QuantSchool, investors can gain a deeper understanding of the platform's investment strategy and maximize their profitability in the market.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....


NVOJuly 29, 2025NOVO NORDISK A/S Hits Price Target with 24.77% Profit: QuantWave Forecasts Success  ~2 min.

NOVO NORDISK A/S, a leading pharmaceutical company, recently achieved its price target forecast with a 24.77% profit, as predicted by QuantWave, an automated forecasting platform....


ABBVJuly 25, 2024ABBVIE INC. Hits Price Target Forecast with 10.78% Profit - QuantWave Success Story  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again proven its accuracy with the recent achievement of a price target forecast for the stock ABBVIE INC....


REGNAugust 13, 2024Successfully Achieved Price Target Forecast for Regeneron Pharmaceuticals, Inc. with 19.42% Profit  ~1 min.

QuantWave, the automated forecasting platform, recently celebrated the successful achievement of its price target forecast for Regeneron Pharmaceuticals, Inc....


AZNApril 25, 2024ASTRAZENECA PLC Hits Price Target Forecast with 13.92% Profit Margin  ~1 min.

On March 19, 2024, QuantWave's forecast signal for ASTRAZENECA PLC indicated a long position at a price of $64.09. The prediction proved to be accurate as the stock reached the target price of $73....